By
Dr Andy Souers2023-06-08T16:00:38
Dr Andy Souers highlights the unwavering commitment to finding an enhanced therapeutic approach that eliminates the need for chemotherapy in blood cancer treatment. This transformative discovery represents a significant leap forward in the way we combat this complex disease, offering new hope to countless patients worldwide.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-08T12:00:00Z
2026-07-08T09:00:00Z
2026-07-08T07:58:00Z
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2026-07-07T12:00:00Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2026-06-15T11:00:00
Sponsored by Miltenyi Biotec
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, By Drug Target Review
2026-07-10T06:15:00
Contributor Professor Donald E Ingber, By Drug Target Review
Site powered by Webvision Cloud